Description

INJ ROXIM-S 2.25 GM combines Cefuroxime, a second-generation cephalosporin antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefuroxime acts by interfering with bacterial cell wall formation, while Sulbactam inhibits certain bacterial beta-lactamase enzymes. The combination is formulated for the management of selected susceptible bacterial infections where clinically appropriate. Its injectable form is intended for administration by trained medical professionals in suitable healthcare settings. Treatment decisions should consider the infection type, antibiotic susceptibility, and relevant prescribing guidelines. Use only under the supervision of a registered healthcare professional.